This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
On March 23, DEA published a proposed rulemaking —“Controls to Enhance the Cultivation of Marihuana for Research in the United States”—in the Federal Register (85 FR 16292), involving who can grow cannabis in bulk for research purposes.
This Wednesday, January 15th, at 10 am EST, the House Energy and Commerce Subcommittee on Health will hold a legislative hearing entitled “Cannabis Policies for the New Decade.” Strait, Senior Policy Advisor, Diversion Control Division, Drug Enforcement Administration (DEA). Douglas Throckmorton, M.D., Volkow, M.D.,
Legislation unanimously passed by members of the US Senate empowers the US Attorney General to facilitate clinical research trials involving cannabis. 253 in the final weeks of the legislative session. Senate Unanimously Approves Legislation Providing US Attorney General with Greater Say in Cannabis Research Decisions.
Members of the House Energy and Commerce Subcommittee on Health today held a legislative hearing, “ Cannabis Policies for the New Decade ,” during which they considered multiple legislative bills aimed at amending federal cannabis laws. Witnesses at today’s hearing were: Matthew J. Douglas Throckmorton, M.D.,
The FDA refers to this program as the expanded access program on their website. While they offer approved clinical trials that can offer patients the ability to try potential therapeutic options, many patients are unable to participate in clinical trials, and this is where the importance of the Right to Try programs comes into play.
Sure, this is further than the legislation has gotten before, but there’s still a LONG way to go on this. MORE & HOPE Banking isn’t the only cannabis-related legislation working its way through the halls of Congress. MORE & HOPE Banking isn’t the only cannabis-related legislation working its way through the halls of Congress.
The Department of Justice’s Office of Legal Counsel released a memo finding that the Drug Enforcement Administration’s cannabis research program is non-compliant with international drug laws. This may provide some context for the DEA’s recent proposed rules overhauling its research program. handy dandy chart.
The DEA faces a lawsuit over their hemp rule. The USDA’s relief aid program opens to hemp growers. As we reported last week, the governor could go either way on this legislation. Marijuana Business Daily has a look at what the future may hold for the legislation. dea regulations. Now, they’re suing.
A researcher filed suit against the DEA, claiming the cannabis she was required to use in her work was “sub-par.” In other federal news, the DEA confirmed that “hemp plants and cannabidiol (CBD) preparations at or below the 0.3 Legislators are considering turning to private dispensaries instead.
Hemp growers and processors are required to register annually with DATCP as part of the state’s Hemp Research Program, which will continue through the 2021 growing season. “There’s been some constant change with the federal government, how they’ve taken that program and then states have had to adjust.
And speaking of CBD, Seyfarth has a program coming up on that topic. In other news, a federal court ruled that the state must turn over information concerning three marijuana businesses to the DEA. The DEA said it was necessary for an investigation into the illegal import and transport of marijuana oil from Mexico.
Around 12 marijuana-related bills were proposed in the 2021 Legislative Session. Nebraska legislators pushed an initiative to establish a regulated framework for the cultivation and distribution of medical cannabis on the state’s 2020 ballot. Wyoming Wyoming is among the few states without a medical cannabis program.
This federal and state interplay has resulted in many legislative and regulatory changes at the state level. In light of these legislative changes, we are presenting a 50-state series analyzing how each jurisdiction treats hemp-derived cannabidiol (“Hemp CBD”). The Commission’s letter is worth reading. producers and consumers.'”
In other federal news, the DEA has, yet again, not approved new suppliers of marijuana for research. Or perhaps Senator Dick Durbin’s (D-IL) legislation will pass. The state’s attorney general has approved a pilot program allowing digital payments to medical cannabis dispensaries.
Rather than a ballot initiative , Connecticut, New Mexico, New York, and Virginia legalized the plant for adult-use purposes via a legislative process. They follow in the footsteps of Vermont, which became the first legislative-driven legal cannabis state back in 2018. billion in annual sales by the fourth year of operation.
In Vermont , legislation to establish a marijuana marketplace passed on a second reading in the House. They see legalization as a solution to problems with the medical cannabis program. The Department of Agriculture delayed a requirement that the DEA conduct all THC testing on hemp crops. FEDERAL NEWS.
other known or potential challenges by the participation of States or producers in the domestic hemp production program. other known or potential challenges by the participation of States or producers in the domestic hemp production program. It was presented with bipartisan support but the legislative process can be unpredictable.
Drugs, substances, and certain chemicals used to make drugs are classified into five categories (known as schedules ) depending on the Department of Drug Enforcement Agency (DEA)’s definition of the drug’s acceptable medical use and abuse/dependency potential. More recently, the 2018 Farm Bill expanded hemp legislation.
On Wednesday, July 14, 2021 Senators Chuck Schumer (D-NY), Cory Booker (D-NJ), and Ron Wyden (D-OR) released draft legislation titled the Cannabis Administration and Opportunity Act. Drug Enforcement Agency (DEA) to the Alcohol and Tobacco Tax and Trade Bureau (TTB), the Bureau of Alcohol Tobacco Firearms and Explosives (ATF).
This was part of their “Hemp for Victory Program.” However, in 2004, there was a lawsuit against the Hemp Industries Association and the DEA. Then in 2014, Obama signed the Farm Bill, which would then allow pilot programs for growing hemp, but it still wasn’t supposed to be used commercially. Conditions.
Cannabinoid Hemp Program Regulations (Finally) Finalized. While much attention is focused on New York’s adult-use cannabis market, the CCB and Office of Cannabis Management (OCM) are also responsible for overseeing both the Medical Marijuana and Cannabinoid Hemp Programs. CBD products).
Ohio legislators are busy writing a marijuana law. The DEA sends a letter to Georgia pharmacies. This month, those legislators are adjourning without acting on that directive. Well, apparently the Drug Enforcement Administration (DEA) noted that as well, and they didn’t take kindly to it. makes an appearance in Congress.
If passed, the Department of Regulatory Agencies would be required to develop rules that would allow for therapeutic psychedelic programs at licensed healing centers for adults to receive psychedelic treatments by a trained facilitator. ” Oregon Saw Great Success With Similar Reform.
On July 14, 2021, Senators Chuck Schumer (D-NY), Ron Wyden (D-OR), and Cory Booker (D-NJ) released the discussion draft of historic federal cannabis legalization legislation, the Cannabis Administration and Opportunity Act (CAOA). While unlikely to pass in this Congress, the momentous legislation gives us a roadmap for how the U.S.
“I’m very thankful to have been working with the Drug Policy Alliance throughout this year to introduce and work on several different amendments and pieces of legislation to make our lives better,” Ocasio-Cortez said.
During a hearing Tuesday on eight VA health-related bills under consideration by Congress, VA officials told House lawmakers that as long as marijuana is illegal under federal law, the department cannot support legislation that promotes its role at the VA. Full story at [link].
Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). By Allison Campbell.
Now that Illinois has joined 10 other states and the District of Columbia in legalizing the recreational use and sale of marijuana, what can we expect from this new legislation? Illinois has had several lawmakers who have been working for years on marijuana legislation. January 16, 2020 .
Although both are legal under state law, there are currently 29 states with legislation allowing for medical cannabis and the District of Columbia. Epidiolex, an FDA-approved medication containing CBD (cannabidiol), has been listed as Schedule 5 by the DEA since June 25th, 2019. Cannabis is a schedule 1 substance.
Legislative changes have been proposed to harmonize Washington’s hemp laws with the federal government’s 2018 Farm Bill. A legislative fix is necessary for hemp-derived CBD sales and for out-of-state hemp export. One open issue is how to pay for the hemp-licensing program that is compliant with the 2018 Farm Bill.
At the time of this article’s publishing, thirty states and the District of Columbia have enacted legislation permitting use of medical cannabis. There is no universal handbook for a medical cannabis program. The best way to become familiar with your state’s medical marijuana program is to visit its official website.
We support Delta-8 but feel that it is not the same as CBD or CBG in that these cannabinoids should be treated as dietary supplements (if new Senate legislation passes). Consumers, regulators, and legislators remain in the dark on cannabis. Do you think these new regulations will be challenged in the courts?
The Drug Enforcement Administration [DEA] later followed that move with its own approval of Epidiolex, as well.). In 2018, the FDA approved GW Pharmaceuticals’ epilepsy drug, Epidiolex, which contained CBD as an active ingredient. “CBD is the active ingredient in the approved drug product, Epidiolex.
According to the United States Drug Enforcement Administration (DEA), Schedule One drugs are “drugs with no currently accepted medical use and a high potential for abuse.” The VA has supported legislation to allow VA scientists to conduct their research on cannabis, its benefits, its risks, and potential for abuse. Yes, it has.
New Jersey failed to pass legislation legalizing recreational marijuana. In October, Senator Mitch McConnell directed the DEA to figure out how to distinguish hemp from marijuana. However, protections for state-legal medical marijuana programs were once again included in the recently passed funding bill.
Drug Enforcement Agency (“DEA”). Some physicians and therapists have argued that the Right to Try Act permits them to administer psilocybin to terminally ill patients (since studies are well past the Phase 1 stage), but the DEA has met this with resistance given psilocybin’s status as a Schedule I drug. AIMS Institute, PLLC.
This was part of their “Hemp for Victory Program.” However, in 2004, there was a lawsuit against the Hemp Industries Association and the DEA. Then in 2014, Obama signed the Farm Bill, which would then allow pilot programs for growing hemp, but it still wasn’t supposed to be used commercially. Conditions.
. – Today, ahead of the 50th anniversary—on June 17—of when President Richard Nixon declared the “war on drugs,” Representatives Bonnie Watson Coleman (D-NJ) and Cori Bush (D-MO) unveiled the Drug Policy Reform Act (DPRA), alongside the Drug Policy Alliance, which has been a strategic partner on the development of the legislation.
The resolution states that ABA “urges Congress to enact legislation to exempt from the Controlled Substances Act (CSA) any production, distribution, possession, or use of marijuana carried out in compliance with state laws.”. The report goes on to describe how its recommendations would help resolve some of these issues.
However, when a bill that restricted the medical program was introduced just a few days later, Governor Polis allegedly stopped communicating with the family and other advocates about their wants and needs. . This is something they had been fighting for over the past few years, and they were happy to see it become a reality. .
Note: South Dakota’s weed-legalization legislation is currently facing legal challenges, because no list in this article can be simple. New Mexico and Virginia have approved legislation, and will join this list later in 2021, on June 29 and July 1, respectively.). South Dakota*. Washington. Washington D.C. New Hampshire. North Dakota.
The now-finalized rules originate from a 2020 voter-approved initiative, subsequently approved by the governor and finally implemented by legislative panel. 1, Louisiana’s medical cannabis program allows patients to access smokable whole-plant flower marijuana. Grassroots Federal/State Legislative Highlights.
These agency pronouncements arise against a flurry of legislative, executive and judicial actions which offer hope that the problem of conflicting MJ legality might eventually be ameliorated in one way or another: H.R. such as bhang, ganga, charras, Indian hemp, dagga, hashish, and cannabis resin. 1200 , The SAFE Banking Act, awaits a vote.
The first and more conclusive would be through Congress legislation signed by the President. The second path would be the administrative action by the Drug Enforcement Agency [“DEA”] and its Diversion Control Division. Will the mandate for the DEA be changed to oversee another special agricultural legal crop or a medicine
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content